Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110016042B reveals a novel catalytic method for synthesizing dicoumarin derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN111057729B reveals enzymatic synthesis for high-purity Larotrectinib intermediates. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN104892540B reveals ionic liquid catalysis for naphthooxazinone derivatives offering green synthesis and supply chain advantages for reliable pharmaceutical intermediates supplier.
Patent CN112479937B reveals a high-yield two-step one-pot method for TES buffer, offering cost reduction and purity advantages for pharma manufacturing.
Novel oxidation process improves yield and purity. Reliable supply chain for pharmaceutical intermediates with cost-effective manufacturing solutions.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN109232333B reveals a metal-free method for benzenesulfonyl enamines using iodine catalysis. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN108484517B reveals a metal-free benzoxazole synthesis using NHPI and air. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Efficient synthesis of key agrochemical intermediates via solvent-free decarboxylation. Reduces waste and improves yield for pharmaceutical manufacturing.
Patent CN117701523A reveals solvent-tolerant transaminase for high-purity sitagliptin intermediate manufacturing with significant supply chain cost reduction.
Patent CN114105722A reveals a metal-free fluorination method using SO2F2 gas. Discover cost-effective strategies for high-purity pharmaceutical intermediates manufacturing.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN101560171A reveals a novel synthesis for 5-DNSA. Achieve superior purity and yield for Labetalol production with our scalable pharmaceutical intermediates supply chain solutions.
Novel base-promoted synthesis offers significant cost reduction and scalability for high-purity xanthone manufacturing supply chains globally ensuring reliable procurement.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.
Patent CN113061594A details a robust immobilized transaminase process for sitagliptin intermediates, offering superior stability and simplified solvent systems for cost-effective API manufacturing.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Novel synthesis of (S,E)-1,9-diene-4,6-diyne-3-octadecyl alcohol offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally.